Author

S. P. Webster

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Pathology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:cancer & tumor microenvironment· 2 Organism:mouse· 2 Assay:proteomics· 2 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:imaging· 1

Frequent Co-Authors

N. Z. M. Homer· 2 shared X. Zheng· 2 shared A. Serrels· 1 shared A. Zhang· 1 shared B. R. Walker· 1 shared C. T. Davidson· 1 shared D. J. Mole· 1 shared D. Mole· 1 shared

Activity by Year

2017-2021 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

N. Z. M. Homer

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis

C. T. Davidson, E. Miller, M. Muir, J. C. Dawson, M. Lee, S. Aitken, A. Serrels, S. P. Webster, N. Z. M. Homer, R. Andrew, V. G. Brunton, P. W. F. Hadoke, B. R. Walker

This study investigates the effect of 11β-HSD1 inhibition on tumour growth and angiogenesis in murine models, finding increased SCC tumour growth but no effect on angiogenesis.

bioRxiv · Aug 4, 2021 · PreprintCancer Biology

Kynurenine 3-monooxygenase (KMO) is a critical regulator of renal ischemia-reperfusion injury

X. Zheng, A. Zhang, M. Binnie, K. McGuire, S. P. Webster, J. Hughes, S. Howie, D. Mole

This study shows that KMO inhibition protects against renal ischemia-reperfusion injury in mice by reducing renal damage and inflammation.

bioRxiv · Mar 7, 2018Pathology

Detecting Drug-Target Binding In Cells Using Fluorescence Activated Cell Sorting Coupled With Mass Spectrometry Analysis

K. Wilson, S. P. Webster, J. P. Iredale, X. Zheng, N. Z. M. Homer, N. Pham, M. Auer, D. J. Mole

This paper introduces a new method called TAPS to assess drug-target binding in cells, demonstrating its effectiveness with the challenging KMO target.

bioRxiv · Apr 3, 2017Pharmacology & Toxicology